Related references
Note: Only part of the references are listed.A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
Peter Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification
A. Laroni et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
Roberta Mancuso et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
A. K. Trampe et al.
NEUROLOGY (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Molly R. Perkins et al.
PLOS PATHOGENS (2012)
Sequencing and Analysis of JC Virus DNA From Natalizumab-Treated PML Patients
Carl E. Reid et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Assessment of JC Virus DNA in Blood and Urine from Natalizumab-Treated Patients
Richard A. Rudick et al.
ANNALS OF NEUROLOGY (2010)
Anti-JC Virus Antibodies: Implications for PML Risk Stratification
Leonid Gorelik et al.
ANNALS OF NEUROLOGY (2010)
Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies
Eugene O. Major
ANNUAL REVIEW OF MEDICINE (2010)
Characterization of JC Human Polyomavirus Infection in a Portuguese Population
Ana Matos et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
JCV detection in multiple sclerosis patients treated with natalizumab
Saud A. Sadiq et al.
JOURNAL OF NEUROLOGY (2010)
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study
Luciano Rinaldi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study
Samantha Jilek et al.
LANCET NEUROLOGY (2010)
Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
Adrian Egli et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
Yiping Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Presence, quantitation and characterization of JC virus in the urine of Italian immunocompetent subjects
Andrea Rossi et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients
F Watzinger et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
WA Knowles et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: A 14-month longitudinal study
PD Ling et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Share Paper
